Cross-linked and hydrophobized hyaluronic acid-based controlled drug release systems. (1st September 2018)

• Record Type: Journal Article
• Authors: Csapó, Edit; Szokolai, Hajnalka; Juhász, Ádám; Varga, Norbert; Janovák, László; Dékány, Imre
• Is Part Of: Carbohydrate polymers. Volume 195(2018)
• Page Start: 99
• Page End: 106
• Publication Date: 2018-09-01
• Subjects: Hyaluronic acid -- cross-linkingCross-linking -- hydrophobizationHydrophobization -- Nanocarrier -- Rheology -- controlled drug release; Polysaccharides -- Periodicals; Polysaccharides -- Periodicals; Polysaccharides -- Périodiques; Electronic journals; 547.78
• DOI: 10.1016/j.carbpol.2018.04.073
• Languages: English
• ISSNs: 0144-8617

Abstract

Graphical abstract: Highlights: Hydrophobic ketoprofen drug has been encapsulated into the modified HyA nanocarriers. Charge compensation ratios of negatively-charged HyA chains have been interpreted. Kinetics of the drug release have been studied by in vitro dissolution investigations. Various kinetic models have been used for interpretation of the experimental data. Abstract: This work demonstrates the preparation, structural characterization, and the kinetics of the drug release of hyaluronic acid (HyA)-based colloidal drug delivery systems which contain hydrophobic ketoprofen (KP) as model molecule. Because of the highly hydrophilic character of HyA the cross-linked derivatives at different cross-linking ratio have been synthesized. The hydrophobized variants of HyA have also been produced by modifying the polymer chains with cetyltrimethylammonium bromide (CTAB) at various HyA/CTAB ratios. Due to modifications the coherent structure of HyA changes into an incoherent colloidal system that were verified by rheological investigations. Nearly 70% of the encapsulated KP dissolve from the totally cross-linked HyA carrier but the release rate of KP is about 20% (after 8 h) from the CTAB-modified colloidal system at HyA monomer/CTAB 1:0.8 mass ratio. It has been verified that the modified HyA may be a potential candidate for controlled drug release of hydrophobic KP molecules.